Since 1986, the ability to confer resistance against an otherwise devastating virus by introducing a single pathogen-derived or virus-targeted sequence into the DNA of a potential host plant has had a marked influence on much of the research effort, focus, and shortterm objectives of plant virologists throughout the world. The vast literature on coat protein-mediated protection, for example, attests to our fascination for unraveling fundamental molecular mechanism(s), our (vain) Despite extensive and sometimes elegant experimentation, the molecular mechanism(s) of this viral "crossprotection" have remained elusive and controversial. In some cases, the coat protein (CP) of the protectant virus was thought to be primarily responsible, either by preventing particle disassembly or by re-encapsidating the incoming genome of the more severe challenge virus. However, viroids [240-to 380-nt-long, naked circular single-stranded (ss)RNA pathogens] and mutant viruses making assembly-defective or no detectable CP could also cross-protect against their more severe relatives. Such observations prompted models based on inhibitory interactions between sense and antisense RNAs or between the replicational machineries ofthe two competing pathogens (6). Controversy arose largely because available molecular technology could not resolve which regulatory or coding sequence(s) or polypeptide product(s) from the actively replicating genome of the primary (protectant) pathogen were responsible for interfering with the many replicative processes essential to establish infection by the secondary, related, and more severe virus. In contrast, multiple infections by unrelated viruses sharing a common host are very prevalent in nature. Many aspects of this older story have their parallels in current hypotheses and lack of a unified model for pathogenderived resistance in transgenic plants.
perceived environmental risk issues. Other single dominant, pathogen-derived plant resistance genes have recently been discovered from a wide variety of viruses and are operative in an ever-increasing range of plant species. Additional candidates seem limited only by the effort invested in experimentation and by our ingenuity and imagination. This review attempts to consider, in a critical way, the current state of the art, some exceptions, and some proposed rules. The fina impression, from all the case evidence considered, is that normal virus replication requires a subtie blend of host-and viruscoded proteins, present in critical relative concentrations and at specific times and places. Any unregulated superimposition of interfering protein or nucleic acid species can, therefore, result in an apparently virus-resistant plant phenotype. SOME RECENT HISTORY The concept (1) (2) (3) and reality (4) (3, 5) .
Despite extensive and sometimes elegant experimentation, the molecular mechanism(s) of this viral "crossprotection" have remained elusive and controversial. In some cases, the coat protein (CP) of the protectant virus was thought to be primarily responsible, either by preventing particle disassembly or by re-encapsidating the incoming genome of the more severe challenge virus. However, viroids [240-to 380-nt-long, naked circular single-stranded (ss)RNA pathogens] and mutant viruses making assembly-defective or no detectable CP could also cross-protect against their more severe relatives. Such observations prompted models based on inhibitory interactions between sense and antisense RNAs or between the replicational machineries ofthe two competing pathogens (6) . Controversy arose largely because available molecular technology could not resolve which regulatory or coding sequence(s) or polypeptide product(s) from the actively replicating genome of the primary (protectant) pathogen were responsible for interfering with the many replicative processes essential to establish infection by the secondary, related, and more severe virus. In contrast, multiple infections by unrelated viruses sharing a common host are very prevalent in nature. Many aspects of this older story have their parallels in current hypotheses and lack of a unified model for pathogenderived resistance in transgenic plants.
The advent of improved cell and tissue culture techniques, efficient protocols for Agrobacterium tumefaciens-mediated transformation and plantlet regeneration in dicotyledonous species (7) [and more recent methods for monocot crops (8) (9) (10) ], has permitted, among other applications (11, 12) , the theory of pathogenderived virus resistance to be tested in practice.
Collaboration between researchers at Monsanto and Washington University (St. Louis) led to the first report of CPmediated protection (CPMP) against tobacco mosaic virus (TMV) in tobacco in 1986 (4). Since then, CPMP has been reported for over 20 to outgrow the infection, avoid the damaging disease, and/or diminish their potential to act as sources of inoculum. On hypersensitive hosts, transgenic resistance can be quantified directly by reduced numbers of local lesions (= bioassay for productive sites of infection). Even a reduction in systemic virus titer should help control field epidemics by reducing the efficiency of vector transmission, as with PLRV CPMP and aphids (38, 39) . In this case, PLRV CPMP seems to mimic events in some naturally resistant breeding lines of potato by reducing virus titer and restricting virions to sieve tubes and companion cells of the internal (adaxial) phloem (40).
ON CP-MEDIATED PROTECTION AND PROPOSED MECHANISMS
At the outset it is accurate to say that no consensus model exists for the mechanism of CPMP. The vast literature since 1986 reveals many details unique to each virus-plant-CP system and even some patterns common to several viruses, but recent cases add more exceptions than rules, and prudence dictates a closer examination ofthe precise nature ofthe viral gene construct used, transgene position effects, copy number and transcriptional activity, the extent and site of uninhibited virus replication and spread within the host plant, and secondary effects of transgenesis on host cell metabolism and general stress/disease resistance responses. We may then come closer to understanding how CPMP works.
Early CPMP experiments involved transgenic expression of virus-sense CP gene transcripts, frequently with the adjacent 3'-terminal sequence of the viral genome (for review, see refs. [13] [14] [15] [16] [17] [18] [19] [20] .
Nonfunctional (-AUG) CP mRNAs or antisense CP mRNAs were inactive or only weakly active (41-43) if they also contained the antisense 3'-untranslated Review: Wilson genomic sequence (43) . A direct correlation appeared between the amount of intact, functional CP expressed in planta and the efficacy of CPMP. Higher concentrations of virus inoculum or (partially) unencapsidated viral RNA overcame CPMP. However, these simple rules derived from the first model systems [TMV, tobacco rattle virus, tobacco streak virus, or AIMV in tobacco (4, (44) (45) (46) ] were quickly broken by cucumber mosaic virus (CMV) and potato virus X (PVX), where antisense CP mRNA provided protection (47, 48) , and for PVX and potato virus S [a carlavirus (49) ], where resistance to naked RNA inocula occurred.
We can now add to these "classic" cases of CPMP several recent examples, particularly among members of the aphidtransmitted potato virus Y (PVY; potyvirus) and luteovirus (PLRV) groups, and the thrip-transmitted TSWV, where intentionally truncated, antisense or nonexpressing (-AUG) CP genes have been transformed into plants and have provided measurable protection or even complete immunity against the appropriate parent virus (50) (51) (52) (53) (54) (55) (56) (57) (58) . Recent field tests with the untranslatable tobacco etch virus (TEV) CP RNA lines (50, 51) have shown 100%o resistance to high disease pressure (W. G. Dougherty, personal communication). In all these cases (50) (51) (52) (53) (54) (55) (56) (57) (58) , it may be that some direct form of RNA-RNA interference between the transgene transcript and the challenge virus (especially the low titer PLRV) could account for the resistant phenotype. However, with the truncated TEV CP transgenic plants, it was common for the inoculated leaves to develop symptoms and virus titers similar to control plants, but for the plant to outgrow the infection. This result suggested an interference with virus spread, and some data pointed to the C-terminal domain of the TEV CP as being involved (50 Traditional, functional CP-dependent CPMP has been shown to involve interference with the early events of virus disassembly (61) (62) (63) ; however, data also indicate inhibitory effects on later events in the virus replication cycle (62, 64) , especially in cases where CPMP occurs against viral RNA inoculum (48, 49). Opportunities for multiple levels of interference will depend upon the precise nature of virus-plant interactions, including cell or tissue specificity, both where the CP is expressed and where the virus replicates, and how natural infections move cell-tocell or long distance (17) . Using tissuespecific promoters for TMV CP expression it has been shown that the level of CP in tobacco epidermal cells is most significant for protection against mechanically inoculated virus (65, 66) .
Notable for its failure, tobaccos transformed with the 60-kDa CP precursor of cowpea mosaic comovirus were not protected (even locally) against cowpea mosaic comovirus inoculation, the precursor was not cleaved, and no virus-like capsids were seen (67) .
In general, CPMP operates well only against closely related virus strains (e.g., ref. 68) . Using a range ofTobamoviruses, protection was detectable when their CPs were .60% homologous in amino acid sequence (69) . A low but significant degree of CPMP against unrelated viruses has been claimed for transgenic tobacco plants expressing zucchini yellow mosaic virus, TMV, A1MV, soybean mosaic potyvirus, or CMV CP (58, (70) (71) (72) . It may be that a mechanism independent of CP, such as discussed above for the TEV (-AUG) constructs (50) (51) (52) , is operative in these hitherto exceptional cases.
As data accumulate, subtle, and as yet inexplicable, complexities in the traditional CPMP systems become apparent. (32) .
Recently, a defective version of the multicomponent CMV RNA2 97-kDa putative replicase gene provided homologous protection against CMV Fny (75) and other cucumovirus subgroup I strains (using 500 ,ug of virus per ml or 50 ,g of RNA per ml, inocula) but not those of subgroup II (28) . This protein corresponds to the 54-kDa readthrough domains of TMV and PEBV. In contrast, transgenic tobaccos expressing native, functional A1MV RNA1-and/or RNA2-encoded replicase proteins (P1 and P2)
were not resistant to virus challenge and could even complement RNA1-and/or RNA2-deficient inocula (76) (77) (78) . Similarly, transformed protoplasts expressing the equivalent full-length brome mosaic virus (BMV) RNA2 protein had no resistance to BMV replication and would function in trans to support RNA2-defective BMV replication (79) . Ten independent transgenic lines of tobacco expressing mRNA for the C-terminal domain of the AIMV P2 protein (equivalent to the TMV and PEBV 54-kDa species) were unable to resist A1MV infection (J. F. Bol, personal communication). Transformed tobaccos expressing AlMV P2 with mutations in the conserved GDD motif are now being tested.
Rather unexpectedly, transgenic tobacco lines expressing the 5'-untranslated leader and the complete, or N-terminal half of the 165-kDa open reading frame 1 product of PVX RNA exhibited limited protection (lowered lesion numbers and reduced virus accumulation) against PVX or PVX RNA inocula at 5 ,ug/ml (30) . The C-terminal third and fourth quarters of the 165-kDa polypeptide, containing the conserved NTPbinding and polymerase (GDD) motifs, respectively, conferred no protection (30) . Despite high transcript levels (Northern blots), no open reading frame 1 products could be detected at first in any transgenic line (estimated sensitivity = 0.0002% of total soluble protein), as in the TMV 54-kDa story. However, recent work has detected low but equal amounts of 165-kDa protein in all five PVXsusceptible and two PVX-resistant transgenic lines (C. L. Hemenway, personal communication). Three possible modes of action have been proposed, which could apply singly or in combination to all examples of replicase-mediated resistance described above and below: (i) the 165-kDa protein expressed is an inactive or low-activity variant from the virus population, being derived from a poorly infectious (0.2%) PVX cDNA clone; (ii) the low 165-kDa-protein yield reflects instability/proteolysis in vivo, and the degradation products could act as defective replicase subunits, interfering with the assembly/function of what is presumed to be a complex, multicomponent enzyme (80) The PVX open reading frame 1 story has been further complicated by Baulcombe and colleagues (31) , who showed that changing the GDD motif to GAD, GED, or ADD in transcripts of a highly infectious full-length clone of PVX RNA completely abolished infectivity. When the 84-nt genomic 5'-leader and each of these variant 165-kDa genes (but unfortunately not the wild-type sequence) were expressed in transgenic tobaccos, measurable quantities of PVX 165-kDa protein could be isolated from the 30,000 x g pellet fraction (P30), and two out of four lines expressing the ADD mutation were highly resistant to PVX RNA inocula equivalent to (-leader) were not resistant to TMV inoculation; however, five transgenic lines of the latter construct showed complete (four) or partial (one) resistance to mechanical inoculation with TMV Ul at up to 100 ,ug/ml (20 ,ug/plant) but, more significantly, were almost equally resistant to TMV U2 and U5, tomato mosaic virus, green-tomato atypical mosaic virus, and ribgrass mosaic virus, some of which are distantly related tobamoviruses (83) , and would infect Ul TMV 54-kDa transgenic plants (25) . Restriction digests and sequence analysis revealed that all five resistant lines had a 1.4-kbp insert in the TMV sequence at nt 2875 and that the insert was followed by a direct nine-residue repeat of TMV nt 2867-2875. Terminal sequencing identified the insert as the 1.33-kbp Escherichia coli IS10 (98% homology). The insert caused premature termination of translation of the TMV replicase gene; thus, a "defective" 126-kDa protein was presumed responsible for the highly virus-resistant phenotype (C. Kearney, personal communication).
Although no data exist, there is no reason to exclude the use of replicasederived sequences for protection against dsDNA or ssDNA viruses, and some work is underway using bean golden mosaic geminivirus ALI gene sequences with site-specific mutations in the NTPbinding domain (84) .
As for transgenic resistance conferred by other nonstructural plant viral genes, no resistance was detected in transgenic N-gene tobacco plants expressing the overlapping nonstructural (cysteine-rich; Zn-finger?) 13 -kDa and 16-kDa protein genes of tobacco rattle virus strain PLB, or the unique 29-kDa gene on RNA2 of tobacco rattle virus strain TCM (85) .
Contained within the CP (P3) gene (open reading frame 4) of the luteovirus PLRV, in a different reading frame, is
Review: Wilson open reading frame 5 for a 17-kDa polypeptide (P4). During PLRV infection, the 17-kDa protein apparently accumulates to levels seven times higher than CP (34) . It may be a precursor for the 5'-viral protein linked to the genomic RNA (VPg). It is also predicted to have an N-terminal domain rich in acidic residues with an amphipathic, a-helix (for dimerization?) and a positively charged C-terminal domain (for binding ssRNA?). It may function as a regulatory protein during virus replication or as a discarded scaffolding protein during virus assembly. Whatever its role, transgenic plants expressing a defective PLRV 17-kDa protein with six additional C-terminal histidine residues (to chelate divalent metal ions, disrupt the C-terminal RNAbinding domain, and allow protein purification on Ni2+ columns) were resistant to wild-type PLRV introduced by graft inoculation (34; W. Rohde, personal communication).
A function unique to plant viruses, and consequent upon the architecture of their hosts, is the production of one or three ("triple gene block") polypeptides that "open" the gated intercellular cytoplasmic connections (plasmodesmata) between neighboring cells and allow the infection to spread locally, probably as some viral ribonucleoprotein complex other than a virion (86) (87) (88) (89) (90) . TMV 30-kDa protein is such a cell-to-cell MP and has been shown to have ssRNA binding activity (91 even from inducible geminivirus replicons (93) . Cauliflower mosaic virus and most potyviruses are insect (aphid)-transmitted, by becoming attached to the stylets or foregut by a virus-encoded, bifunctional protein that is believed to recognize the viral CP and a surface receptor in the insect. Mutated or heterologously expressed "helper component" or aphid transmission factor has been shown to interfere with normal virus transmission by membrane feeding (94) . Thus, it may prove possible to prevent the spread of insect-transmitted (or fungus-, or nematode-transmitted) viruses by engineering crops to express a defective virus transmission protein.
Further permutations on this theme seem endless, limited only by the ingenuity and efforts of researchers and the number of nonstructural viral genes characterized. The production of useful resistance is often a by-product of fundamental virological studies to confirm viral gene function. Indeed, as a simplistic extrapolation from current knowledge on the modular evolution of plant viruses, and the resulting conserved (consensus) functional sequence domains, one could speculate that a completely artificial, chimeric transgene containing an array of several (defective) catalytic motifs (e.g., a consensus GDD box, NTP-binding, helicase, and methyltransferase) on the surface of a "neutral" protein gene (e.g., bovine serum albumin), or in a viral CP gene, might confer resistance to a wide range of viruses.
OTHER STRATEGIES
Satellites and DI Nucleic Acids. The ability of some satRNAs (95) to attenuate the symptoms of their helper virus led to their early and widespread use in spray inoculations of greenhouse and field crops. Concurrent with the development of CPMP, transgenic plants expressing symptom-ameliorating satellites of CMV or tobacco ringspot virus (TRSV) were shown to provide protection from the severe effects of their respective helper virus and to inhibit virus replication (96) (97) (98) (99) . CMV satRNA also protected against the symptoms of tomato aspermy virus but without causing any reduction in virus replication. This enigma may be explained by recent observations on the ability of attenuating satRNAs to prevent helper virus CP from entering the chloroplasts of infected cells (P. Tien, personal communication). Thus, reduced replication may not be the (sole) mechanism of satRNA protection. Satellite TRSV also interferes with the replication and disease caused by another nepovirus, cherry leafroll virus, even though cherry leafroll virus is not a helper virus for satellite TRSV (100). Transgenic protection against cherry leafroll virus by satellite TRSV was reported in walnut trees in California in 1988; however, the phenomenon proved nonreproducible (E. Bruening, personal communication).
The mechanisms underlying the use of satRNAs (free or transgenic) seem even more empirical and enigmatic than the other approaches described here. Risk of mutation to a more severe satRNA (a single nucleotide change can be enough), their limited occurrence in nature, and possible changes in helper virus relations have detracted from widespread use ofthe transgenic satRNA protection strategy.
DI RNAs, while common in animal viruses, occur naturally only in members of the Tombusvirus and Carmovirus groups of plant viruses (101-103) and represent complicated rearrangements of genomic sequences. Like satRNAs, they can intensify (103) or ameliorate the symptoms of their helper virus and interfere with its replication (104) . Recently, in barley protoplasts, deletion mutants of BMV RNA2 have been shown to act as artificial DI RNAs (105, 106), or "parasitic RNAs." Interference with BMV RNA replication has also been demonstrated with antisense transcripts of the regulatory intercistronic region from BMV RNA3 (107) . With the advent of routine monocot transformation/regeneration doubtless these DI constructs will be tested in planta. Paradoxically, the first demonstration of a natural DI molecule attenuating virus disease symptoms in a transformed plant involved a defective, subgenomic ssDNA of the B component of African cassava mosaic geminivirus (108, 109) , which interfered with the replication of both African cassava mosaic virus DNA components A and B but did not interfere with those of another geminivirus (tomato golden mosaic virus). DI RNAs of the negative-sense L-segment of TSWV RNA have been identified (110, 111) and shown to reduce symptoms. These may also be future candidates for transgenic protection, although creating TSWV-tolerant rather than immune lines of plants (23) .
Plantibodies. Since the first demonstration that plant cells could chaperone and assemble functional mouse monoclonal antibodies (mAbs) (112) TMV (refs. 47, 48, and 43, respectively) showed only limited protection against inoculum concentrations even lower than those required for CPMP. These antisense constructs also contained part (PVX) or all (CMV and TMV) of the viral 3'-noncoding sequence, which may have accounted for their efficacy by hybridizing to early replication signals on the challenge virus genome. Similarly, transgenic plants expressing antisense RNAs to other regions ofthe CMV genome were generally not resistant to CMV infection (116) , except one line that paradoxically had low transcript levels. Until recently, therefore, transgenic protection using antisense RNA against RNA virus target sequences remained largely unproven. However, an exclusively cytoplasmic RNA-virus replication cycle, high genome-sense RNA copy numbers, and association with proteins at all stages of replication suggest that a simple antisense antiviral strategy is unlikely to be successful.
As discussed above, recent data (50-58) from plants transformed with several potyvirus, luteovirus, or tospovirus CP antisense constructs have rekindled hope for antisense RNA protection against viruses. Use of an antisense intercistronic control sequence from BMV RNA3 (107) to interfere with virus replication in protoplasts has also been mentioned above.
Antisense inhibition of plant nuclear gene expression is well-documented (117), supporting some utility against viruses with a nuclear phase in their replication cycle-for example, geminiviruses (118, 119) , caulimoviruses, or badnaviruses.
Ribozymes are small RNA molecules derived from satellite TRSV, or certain viroids and viroid-like satRNAs, which are capable of highly specific catalytic cleavage of RNA (for reviews, see refs. 120 and 121). Although the cleavage is normally intramolecular, the catalytic domain (a hairpin or hammerhead structure, respectively) and flanking antisense arms can be designed (122, 123) to cleave a specific target RNA in trans (before or after a GUC triplet, respectively). The hammerhead will also cleave 3' of GUA or GUU. Ribozymes can be visualized as 6"warheaded" antisense RNAs; however, the length and base composition of the two arms will affect the hybridization on/off rates at a given temperature and, hence, the kinetics and efficiency of RNA cleavage. Although much success has been achieved in vitro, progress in vivo has been markedly slower, requiring ribozyme/target RNA ratios between 100:1 and 1000:1 to detect activity, and a significant proportion of the downregulation has been attributed to the antisense arms rather than to RNA cleavage. Most recently in plant protoplasts, neomycin phosphotransferase activity was completely abolished by a transiently expressed ribozyme (124) and, in mouse mammary cells, a ribozyme against a-lactalbumin expressed at a ratio of 1000:1 via the T7-vaccinia virus delivery system, reduced a-lactalbumin activity by >80% (125 Latent Suicide Genes. When a plant cell is transformed to express a low, constitutive level of antisense RNA for a highly phytotoxic protein (e.g., diphtheria toxin A fragment, pokeweed antiviral protein, or ricin) with a minus-sense plant viral subgenomic RNA promoter at its 3'-end, then infection by the cognate virus will, during the production of progeny plusstrands and subgenomic RNAs, transcribe the nonsense RNA into mRNA, allowing expression of the phytotoxin and killing that cell.
By use of the PVX subgenomic RNA promoter and diphtheria toxin mRNA, transgenic tobaccos showed a 20-fold reduction in PVX concentration in upper, systemic leaves, and the PVX-inoculated leaves turned yellow and fell off 6-7 days after inoculation (J. G. Atabekov, personal communication). Comparable constructs for transient gene expression (but containing an antisense ricin or bacterial exotoxin gene and TMV replication signals) were toxic to protoplasts, even without a virus challenge-presumably due to low-level transcription in the opposite direction from the 35S promoter (T. Hohn, personal communication). This general approach may be of questionable utility in the field but can provide a useful and sensitive probe for transcriptional activity.
THE FINAL WORD-ON RISK ISSUES CONCERNED WITH
PATHOGEN-DERIVED RESISTANCE Transgenic plants expressing viral pathogen-derived sequences have been considered sites for hyperevolution of viruses through recombination between a mild or defective viral genome (DNA or RNA) and the transgene or its transcript (127) . To date, there is no experimental evidence to confirm that this can occur. On the contrary, evidence against such events exists through one (128) (129) (130) or eight (15) viral passages. Nevertheless, transencapsidation or heteroencapsidation of viral RNAs by transgenically expressed CP does occur (128) (129) (130) (131) . Most recently, the CP of plum pox potyvirus has been shown to confer aphid-transmissibility on a nontransmissible isolate of zucchini yellow mosaic virus (130) . Although this may alter the vector relations and spread of a virus in a CPtransgenic monoculture or even the host range of a virus (if a different vector species became involved), the effect would apply only for a single acquisitiontransmission cycle. Any long-term, stable effects, genetic or epidemiological, would seem remote-but are now amenable to direct experimentation and more accurate risk assessment using the exten-sive range of plant species transformed singly or combinatorially (132) (133) (134) (132, 133) and, in general, exhibits greater susceptibility to virus challenge, probably through added environmental stresses. Nevertheless, useful virus-resistant lines can be selected (133) .
In conclusion, I am confident that we shall continue to be amused and amazed by the ingenuity and unpredictability of future strategies for pathogen-derived resistance to viruses. Let us hope that all this effort, new information, and experimental material also contribute to our knowledge and understanding of conventional virus-plant interactions. 
